Intraoperative cell salvage during radical prostatectomy: A safe technique for Jehovah's witnesses

International Braz J Urol

Volumn 30, Issue 5, 2004, Pages 377-379

  Nieder, Alan M ^a   Simon, Michael A ^a   Kim, Sandy S ^a   Manoharan, Murugesan ^a   Soloway, Mark S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cell salvage; Jehovah's witness; Prostate cancer; Prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLOOD; BLOOD CELL; BLOOD TRANSFUSION; CANCER LOCALIZATION; CASE REPORT; DIAGNOSTIC PROCEDURE; HUMAN; INTRAOPERATIVE PERIOD; JEHOVAH'S WITNESS; MALE; PROSTATE CANCER; PROSTATECTOMY; SAFETY; SALVAGE THERAPY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 9244255889     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382004000500003     Document Type: Article

References (13)

1. Moul JW, Sun L, Wu H, McLeod DG, Amling C, Lance R, et al.: Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national database. Urol Oncol. 2003; 21: 447-55.
2. Goh M, Kleer CG, Kielczewski P, Wojno KJ, Kim K, Oesterling JE: Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary? Urology. 1997; 49: 569-73; discussion 574.
3. Lance RS, Freidrichs PA, Kane C, Powell CR, Pulos E, Moul JW, et al.: A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group. BJU Int. 2001; 87: 61-5.
4. Goodnough LM, Grishaber JE, Birkmeyer JD, Monk TG, Catalona WJ: Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology. 1994; 44: 226-31.
5. Rosenblum N, Levine MA, Handler T, Lepor H: The role of preoperative epoetin alfa in men undergoing radical retropubic prostatectomy. J Urol. 2000; 163: 829-33.
6. Monk TG, Goodnough LT, Brecher ME, Pulley DD, Colberg JW, Andriole GL, et al.: Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg. 1997; 85: 953-8.
7. Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ: Intraoperative cell salvage in radical retropubic prostatectomy. Urology. 2001; 58: 740-5.
8. Davis M, Sofer M, Gomez-Marin O, Bruck D, Soloway MS: The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? BJU Int. 2003; 91: 474-6.
9. Ward JF, Nowacki M, Sands JP, Conner RJ, Huisman TK: Malignant cytological washings from radical prostatectomy specimens: a possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease. J Urol. 1996; 156: 1381-4; discussion 1384-5.
10. Klimberg I, Sirois R, Wajsman Z, Baker J: Intraoperative autotransfusion in urologic oncology. Arch Surg. 1986; 121: 1326-9.
11. Hart OJ 3rd, Klimberg IW, Wajsman Z, Baker J: Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet. 1989; 168: 302-6.
12. Moskowitz DM, Perelman SI, Cousineau KM, Klein JJ, Shander A, et al.: Multidisciplinary management of a Jehovah's Witness patient for the removal of a renal cell carcinoma extending into the right atrium. Can J Anaesth. 2002; 49: 402-8.
13. Nieder AM, Rosenblum N, Lepor H: Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. Urology. 2001; 57: 737-41.